8 results for "Cal Robinson"

WCN24-634 SAFETY AND PRACTICAL USE OF 4% TETRASODIUM EDTA (KITELOCK™) FOR PEDIATRIC HEMODIALYSIS LINE LOCKING

Cal Robinson; Rose Nemec; Lor Tecson et al.

Kidney International Reports, Vol. 9 No. 4 · 2024 · English · DOAJ Scopus

Treatment of Pediatric Colchicine Poisoning with Single-Pass Albumin Dialysis: A Case Report

Atessa Bahadori; Rishil Patel; Cal Robinson et al.

Case Reports in Nephrology and Dialysis, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

Introduction: Colchicine has a narrow therapeutic index, and doses >0.5 mg/kg are considered toxic with a high mortality rate. Case Presentation: A previously healthy 15-year-old presents to the emergency department with abdominal pain and vomiting following intentional ingestion of colchicine…

Barriers and Opportunities to Increase Utilization of Donor Kidneys After Death Determined by Circulatory Criteria Among Children and Adults: A Narrative Review

Cal Robinson; Adrianna Douvris; Waleed Rahmani et al.

Canadian Journal of Kidney Health and Disease, Vol. 12 · 2025 · English · DOAJ Scopus

Purpose of Review: Kidney transplantation is associated with survival benefit compared to dialysis. Yet, there is an unmet need for access to kidney transplantation within Canada and globally. Donation after death determined by circulatory criteria (DCC) has expanded access to kidney…

Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team

Cal Robinson; Michelle Ruhl; Amrit Kirpalani et al.

Canadian Journal of Kidney Health and Disease, Vol. 7 · 2020 · English · DOAJ Scopus

Purpose: The goal of these recommendations is to provide guidance on the optimal care of children with glomerular diseases during the COVID-19 pandemic. Patients with glomerular diseases are known to be more susceptible to infection. Risk factors include decreased vaccine uptake, urinary loss of…

WCN24-636 PROLONGED REMISSION AFTER CYCLOPHOSPHAMIDE AND TACROLIMUS TREATMENT IN CHILDHOOD NEPHROTIC SYNDROME: A PROSPECTIVE COHORT STUDY

Cal Robinson; Nowrin Aman; Tonny Banh et al.

Kidney International Reports, Vol. 9 No. 4 · 2024 · English · DOAJ Scopus

WCN24-907 Long-term cardiovascular outcomes in children and adolescents with hypertension: A population-based, propensity-matched cohort study

Cal Robinson; Nivethika Jeyakumar; Graham Smith et al.

Kidney International Reports, Vol. 9 No. 4 · 2024 · English · DOAJ Scopus

Associations Between Toxic Metal Exposure and Childhood Nephrotic Syndrome

Cal Robinson; Nowrin Aman; Harshita Arora et al.

Kidney International Reports, Vol. 11 No. 4 · 2026 · English · DOAJ Scopus

Introduction: Mercury intoxication causes nephrotic syndrome in children and adults. It is unknown if chronic low-grade metal exposure is a risk factor for childhood nephrotic syndrome. We aimed to evaluate the associations between metal exposure and childhood nephrotic syndrome outcomes. Methods…

Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome

Eugene Yu-hin Chan; Chun Ting Au; Ellen LM. Yu et al.

Kidney International Reports, Vol. 11 No. 6 · 2026 · English · DOAJ Scopus

Introduction: The efficacy and safety of rituximab in children aged < 6 years with frequently-relapsing and/or steroid-dependent nephrotic syndrome (FRSDNS) remain controversial. Methods: We conducted a retrospective cohort study at 16 pediatric nephrology centers from 10 countries in Asia, Europe…